Neoantigens are tumor-specific antigens that arise due to mutations in cancer cells. These antigens are not present in normal tissues, making them ideal targets for the immune system. Neoantigen-targeted therapies are being explored to develop personalized cancer vaccines and adoptive T cell therapies.
